Outcomes of patients with loco-regionally recurrent or new primary squamous cell carcinomas of the head and neck treated with curative intent reirradiation at Mayo Clinic

[1]  D. Heron,et al.  A prospective phase 2 trial of reirradiation with stereotactic body radiation therapy plus cetuximab in patients with previously irradiated recurrent squamous cell carcinoma of the head and neck. , 2015, International journal of radiation oncology, biology, physics.

[2]  E. Genden,et al.  Recurrent and second primary squamous cell carcinoma of the head and neck: When and how to reirradiate , 2015, Head & neck.

[3]  A. Garden,et al.  Improved survival using intensity‐modulated radiation therapy in head and neck cancers: A SEER‐Medicare analysis , 2014, Cancer.

[4]  D. Heron,et al.  Stereotactic Body Radiotherapy (SBRT) for primary and recurrent head and neck tumors. , 2013, Oral oncology.

[5]  C. Rödel,et al.  Reirradiation with cetuximab in locoregional recurrent and inoperable squamous cell carcinoma of the head and neck: feasibility and first efficacy results. , 2012, International journal of radiation oncology, biology, physics.

[6]  C. Schultz,et al.  Continuous-course reirradiation with concurrent carboplatin and paclitaxel for locally recurrent, nonmetastatic squamous cell carcinoma of the head-and-neck. , 2012, International journal of radiation oncology, biology, physics.

[7]  P. Johnstone,et al.  Risk of carotid blowout after reirradiation of the head and neck: a systematic review. , 2012, International journal of radiation oncology, biology, physics.

[8]  G. Kornek,et al.  Re-irradiation combined with capecitabine in locally recurrent squamous cell carcinoma of the head and neck , 2012, Strahlentherapie und Onkologie.

[9]  Joshua D. Lawson,et al.  ACR appropriateness criteria retreatment of recurrent head and neck cancer after prior definitive radiation expert panel on radiation oncology-head and neck cancer. , 2011, International journal of radiation oncology, biology, physics.

[10]  J. Pignon,et al.  Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): a comprehensive analysis by tumour site. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[11]  G. Calais,et al.  Randomized phase III trial (GORTEC 98-03) comparing re-irradiation plus chemotherapy versus methotrexate in patients with recurrent or a second primary head and neck squamous cell carcinoma, treated with a palliative intent. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[12]  A. Meyer,et al.  Re-irradiation of head and neck cancer-impact of total dose on outcome. , 2010, Anticancer research.

[13]  C. Belka,et al.  Reirradiation with Alternating Docetaxel-Based Chemotherapy for Recurrent Head and Neck Squamous Cell Carcinoma , 2010, Strahlentherapie und Onkologie.

[14]  T. Padhya,et al.  Prognostic factors for survival after salvage reirradiation of head and neck cancer. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  M. B. Gillespie,et al.  Toxicity and survival outcomes of hyperfractionated split‐course reirradiation and daily concurrent chemotherapy in locoregionally recurrent, previously irradiated head and neck cancers , 2009, Head & neck.

[16]  Jerome H. Liu,et al.  Reirradiation after Salvage Surgery and Microvascular free flap Reconstruction for Recurrent Head and Neck Carcinoma , 2008, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[17]  V. Grégoire,et al.  Randomized trial of postoperative reirradiation combined with chemotherapy after salvage surgery compared with salvage surgery alone in head and neck carcinoma. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  R. Weichselbaum,et al.  Phase I study of bevacizumab added to fluorouracil- and hydroxyurea-based concomitant chemoradiotherapy for poor-prognosis head and neck cancer. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  S. Spencer,et al.  Final report of RTOG 9610, a multi‐institutional trial of reirradiation and chemotherapy for unresectable recurrent squamous cell carcinoma of the head and neck , 2008, Head & neck.

[20]  K. Ang,et al.  Phase II study of low-dose paclitaxel and cisplatin in combination with split-course concomitant twice-daily reirradiation in recurrent squamous cell carcinoma of the head and neck: results of Radiation Therapy Oncology Group Protocol 9911. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  J. Mechalakos,et al.  Salvage re-irradiation for recurrent head and neck cancer. , 2007, International journal of radiation oncology, biology, physics.

[22]  J. Bourhis,et al.  Phase I trial of tirapazamine, cisplatin, and concurrent accelerated boost reirradiation in patients with recurrent head and neck cancer. , 2007, International journal of radiation oncology, biology, physics.

[23]  R. de Bree,et al.  Results of postoperative reirradiation for recurrent or second primary head and neck carcinoma , 2006, Cancer.

[24]  C. Leemans,et al.  A phase II study of primary reirradiation in squamous cell carcinoma of head and neck. , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[25]  E. Vokes,et al.  Long-term outcome of concurrent chemotherapy and reirradiation for recurrent and second primary head-and-neck squamous cell carcinoma. , 2006, International journal of radiation oncology, biology, physics.

[26]  E. Horwitz,et al.  Toxicity and outcome analysis of patients with recurrent head and neck cancer treated with hyperfractionated split‐course reirradiation and concurrent cisplatin and paclitaxel chemotherapy from two prospective phase I and II studies , 2005, Head & neck.

[27]  A. Rademaker,et al.  Patterns of failure, prognostic factors and survival in locoregionally advanced head and neck cancer treated with concomitant chemoradiotherapy: a 9-year, 337-patient, multi-institutional experience. , 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

[28]  G. Weinstein,et al.  Pilot study of postoperative reirradiation, chemotherapy, and amifostine after surgical salvage for recurrent head-and-neck cancer. , 2004, International journal of radiation oncology, biology, physics.

[29]  N. Datta,et al.  Chemo-reirradiation in persistent/recurrent head and neck cancers. , 2004, Japanese journal of clinical oncology.

[30]  T. Akiba,et al.  Prognostic Factors of Reirradiation for Recurrent Head and Neck Cancer , 2002, American journal of clinical oncology.

[31]  J. Bourhis,et al.  Full dose reirradiation combined with chemotherapy after salvage surgery in head and neck carcinoma , 2001, Cancer.

[32]  L. Dawson,et al.  Conformal re-irradiation of recurrent and new primary head-and-neck cancer. , 2001, International journal of radiation oncology, biology, physics.

[33]  N. Willich,et al.  Recurrent head and neck cancer: retreatment of previously irradiated areas with combined chemotherapy and radiation therapy-results of a prospective study. , 2000, Radiology.

[34]  W. Goodwin.  Salvage Surgery for Patients With Recurrent Squamous Cell Carcinoma of the Upper Aerodigestive Tract: When Do the Ends Justify the Means? , 2000, The Laryngoscope.

[35]  S. Spencer,et al.  Concomitant chemotherapy and reirradiation as management for recurrent cancer of the head and neck. , 1999, American Journal of Clinical Oncology.

[36]  S. Nag,et al.  Intraoperative electron beam radiotherapy for previously irradiated advanced head and neck malignancies. , 1998, International journal of radiation oncology, biology, physics.

[37]  J. Bourhis,et al.  Full-dose reirradiation for unresectable head and neck carcinoma: experience at the Gustave-Roussy Institute in a series of 169 patients. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[38]  P. Rubin,et al.  Second malignancies in patients who have head and neck cancer: incidence, effect on survival and implications based on the RTOG experience. , 1989, International journal of radiation oncology, biology, physics.

[39]  M. Bignardi,et al.  Reirradiation of recurrent head and neck cancers , 1987, The Laryngoscope.

[40]  A. Jemal,et al.  Cancer statistics, 2015 , 2015, CA: a cancer journal for clinicians.

[41]  P. Dirix,et al.  Outcome after Re-Irradiation of Head and Neck Cancer Patients , 2010, Strahlentherapie und Onkologie.

[42]  G. Calais,et al.  Final results of the 94-01 French Head and Neck Oncology and Radiotherapy Group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[43]  P. François,et al.  [Hyperfractionated reirradiation after salvage surgery in cervico-facial carcinoma. Result of a pilot study in 14 patients]. , 1997, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

[44]  P. Giraud,et al.  Réirradiation hyperfractionnée après chirurgie de rattrapage de carcinomes cervicaux-faciaux. Résultat d'une étude pilote de 14 patients , 1997 .